L-sn-1-O-oleoyl-2-O-methylglyceryl-3-phosphothionate (2S-OMPT)
![]() ![]() |
Catalog No.: L-9418 MW: 466.61 CAS: 645408-61-3 Description: OMPT is a metabolically-stabilized analog of Lysophosphatidic Acid (LPA) which acts as potent agonist for the LPA3 receptor. Of the two enantiomers, (2S)-OMPT is more potent than (2R)-OMPT showing 5-20 fold more activity in calcium release from LPA3-transfected Sf9 and rat hepatoma Rh7777 cells. (2S)-OMPT is also more potent in inducing calcium release, IL-6 production, and MAPK and Akt phosporylation in OVCAR3 cells. |
|||||||
Storage-20 °CFeatured in Publication1) Lin, D. A. and J. A. Boyce (2005). "IL-4 regulates MEK expression required for lysophosphatidic acid-mediated chemokine generation by human mast cells." J Immunol 175(8): 5430-8.2) Zhao, C., M. J. Fernandes, et al. (2008). "Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis?" Mol Pharmacol 73(2): 587-600. 3) Qian, L., Y. Xu, et al. (2003). "Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity." J Med Chem 46(26): 5575-8. |
||||||||
|
||||||||
Additional Information:
Tech Data Sheet - TDS_L-9418_Rev 2 |
||||||||
|